EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cancer terminator viruses: Unique conditionally replication competent oncolytic viruses producing therapeutic anti-cancer immunomodulating agents

Pritam Kumar Roy, Shahid Maqbool Mir, Narsimha Mamidi, Padmanabhan Mannangatti, Theresa Gammel, David D Limbrick, Devanand Sarkar, Swadesh K Das, Paul B Fisher

Advances in Cancer Research · 2026 · 321-374

DOI: 10.1016/bs.acr.2026.02.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Cancer Research, 2026. Verfasst von Pritam Kumar Roy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular, Molecular and Genetic Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA; VCU Institute of Molecula…. Hauptthemen laut MEDLINE: Neoplasms, Oncolytic Viruses, Oncolytic Virotherapy, Immunomodulating Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 176 Literaturangaben. Gefördert von: Mount Sinai Children's Center Foundation, Sanford Burnham Prebys, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsOncolytic VirusesOncolytic VirotherapyImmunomodulating AgentsHumansAnimalsVirus ReplicationAdenoviridaeGenetic VectorsImmunotherapy

Stichwörter der Autor:innen

Cancer immunotherapyCancer terminator virusConditionally oncolytic adenovirusCytokine gene therapyMda-7/il-24Oncolytic adenovirusPEG-3 promoterTumor-selective replicationViro-immunotherapy

Substanzen

Immunomodulating Agents

Autor:innen und Institutionen

  • Department of Cellular, Molecular and Genetic Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA; VCU Institute of Molecular Medicine, Virginia Commonwealth University, School of Medicine, Rich…
  • Department of Neurosurgery, Virginia Commonwealth University, School of Medicine, Richmond, VA.

Förderung

  • Mount Sinai Children's Center Foundation
  • Sanford Burnham Prebys
  • National Cancer Institute
  • Commonwealth Health Research Board
  • National Foundation for Cancer Research
  • National Institutes of Health
  • Massey Comprehensive Cancer Center, Virginia Commonwealth University

Zitieren

APA

Roy, P. K., Mir, S. M., Mamidi, N., Mannangatti, P., Gammel, T., Limbrick, D. D., Sarkar, D., Das, S. K., & Fisher, P. B. (2026). Cancer terminator viruses: Unique conditionally replication competent oncolytic viruses producing therapeutic anti-cancer immunomodulating agents. Advances in Cancer Research, 321-374. https://doi.org/10.1016/bs.acr.2026.02.007

Vancouver

Roy PK, Mir SM, Mamidi N, Mannangatti P, Gammel T, Limbrick DD, et al. Cancer terminator viruses: Unique conditionally replication competent oncolytic viruses producing therapeutic anti-cancer immunomodulating agents. Advances in Cancer Research. 2026:321-374. doi:10.1016/bs.acr.2026.02.007

BibTeX
@article{Roy2026,
  author = {Roy, Pritam Kumar and Mir, Shahid Maqbool and Mamidi, Narsimha and Mannangatti, Padmanabhan and Gammel, Theresa and Limbrick, David D and Sarkar, Devanand and Das, Swadesh K and Fisher, Paul B},
  title = {Cancer terminator viruses: Unique conditionally replication competent oncolytic viruses producing therapeutic anti-cancer immunomodulating agents},
  journal = {Advances in Cancer Research},
  year = {2026},
  pages = {321--374},
  doi = {10.1016/bs.acr.2026.02.007}
}
Kostenlos starten →